title: Letter by Kurtoglu et al regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke".
authors.affiliation: Department of Cardiology, Elazig Training and Research Hospital, Elazig, Turkey.
authors.forename: Ertugrul
authors.initials: E
authors.lastname: Kurtoglu
authors.forename: Sevket
authors.initials: S
authors.lastname: Balta
authors.forename: Isa
authors.initials: I
authors.lastname: Sincer
authors.forename: Hasan
authors.initials: H
authors.lastname: Korkmaz
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D004921:Erythropoietin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D020521:Stroke / Q000188:drug therapy* / Q000378:metabolism*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D004921:Erythropoietin; D001120:Arginine; D010959:Tissue Plasminogen Activator